Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
Official title: Study on the Management of COMISA
Run by University Hospital, Grenoble · NCT07743931 · Data updated 2026-11-12
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 5 sites (Grenoble and 4 other locations) |
| Status | Recruiting |
| Started | September 30, 2026 |
| Main results expected | September 2028 |
| Study ends | September 2029 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT07743931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults diagnosed with COMISA (AHI ≥ 15 and ISI ≥ 15), CPAP‑naïve, and with no prior daridorexant treatment, affiliated with a national health insurance system.
✕Probably not a fit
Patients who cannot tolerate CPAP or daridorexant, or who have contraindications to daridorexant, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
COMISA is the co-occurrence of obstructive sleep apnea and insomnia. This minimal-risk interventional study will look at how a sleep‑wake medication (daridorexant 50 mg) given alongside CPAP affects adherence to CPAP and overall treatment outcomes in adults with COMISA. Participants must have AHI ≥ 15 and ISI ≥ 15, be CPAP‑naïve, and have no prior daridorexant treatment. The intervention combines standard CPAP therapy with daridorexant as part of routine care, with study procedures designed to reflect real-world practice. Outcomes will inform whether this combined approach improves sleep symptoms and device use in this patient group.
Why it matters
Potential benefit: If successful, patients could experience better sleep and higher CPAP adherence, potentially improving daytime functioning and quality of life.
How similar studies have gone: There is limited prior evidence on combining insomnia medications with CPAP for COMISA; this approach is innovative with some supportive data for each component separately.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient diagnosed with COMISA, defined by an apnea-hypopnea index (AHI) ≥ 15 events/hour and an Insomnia Severity Index (ISI) score ≥ 15, newly diagnosed and naïve to CPAP therapy and daridorexant treatment (no treatment for \> 5 years). * Prescription of continuous positive airway pressure (CPAP) therapy combined with a prescription of daridorexant. * Patient has provided informed consent to participate in the study. * Patient is affiliated with a national health insurance system. Exclusion Criteria: * Severe hepatic impairment (contraindication to daridorexant treatment). * Refusal of CPAP therapy and/or refusal of daridorexant treatment. * Individuals covered under Articles L1121-5 to L1121-8 of the French Public Health Code. * Staff members who have a hierarchical relationship with the principal investigator. * Any patient who, in the opinion of the investigator, would be unable to comply with study procedures or the study schedule.
Where it's running
-
CHU Grenoble Alpes
Grenoble, France Recruiting -
Hôpital Européen Marseille
Marseille, France Not yet recruiting -
Centre Médical Les Jasmins
Metz, France Not yet recruiting -
Hôpital de la Pitié Salpêtrière - AP-HP
Paris, France Not yet recruiting -
Polyclinique Saint-Laurent - Hospitalité Saint-Thomas de Villeneuve
Rennes, France Not yet recruiting
Study contacts
- Principal investigator: Jean-Louis PEPIN, Pr — Grenoble Alpes University Hospital
- Study coordinator: Robin TERRAIL
- Email: rterrail@chu-grenoble.fr
- Phone: +33476767166
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.